Millennium Management’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-548,616
| Closed | -$3.31M | – | 4879 |
|
|
2019
Q4 | $3.31M | Sell |
548,616
-2,739,006
| -83% | -$15.9M | ﹤0.01% | 2248 |
|
|
2019
Q3 | $11.8M | Sell |
3,287,622
-1,041,082
| -24% | -$4.01M | 0.02% | 1166 |
|
|
2019
Q2 | $11.6M | Sell |
4,328,704
-815,469
| -16% | -$2.41M | 0.02% | 1141 |
|
|
2019
Q1 | $15.2M | Buy |
5,144,173
+3,065,761
| +148% | +$7.53M | 0.02% | 971 |
|
|
2018
Q4 | $3.31M | Buy |
2,078,412
+695,443
| +50% | +$1.97M | 0.01% | 1869 |
|
|
2018
Q3 | $5.09M | Buy |
1,382,969
+1,266,635
| +1,089% | +$3.77M | 0.01% | 1786 |
|
|
2018
Q2 | $329K | Sell |
116,334
-63,691
| -35% | -$217K | ﹤0.01% | 3346 |
|
|
2018
Q1 | $668K | Sell |
180,025
-36,415
| -17% | -$119K | ﹤0.01% | 2903 |
|
|
2017
Q4 | $623K | Sell |
216,440
-189,760
| -47% | -$689K | ﹤0.01% | 2978 |
|
|
2017
Q3 | $1.82M | Sell |
406,200
-2,609,991
| -87% | -$11.6M | ﹤0.01% | 2222 |
|
|
2017
Q2 | $13.8M | Buy |
3,016,191
+1,096,449
| +57% | +$4.41M | 0.02% | 871 |
|
|
2017
Q1 | $8.08M | Buy |
1,919,742
+788,819
| +70% | +$3.28M | 0.01% | 1148 |
|
|
2016
Q4 | $4.67M | Buy |
1,130,923
+1,067,461
| +1,682% | +$5.67M | 0.01% | 1367 |
|
|
2016
Q3 | $514K | Sell |
63,462
-3,165,173
| -98% | -$26.9M | ﹤0.01% | 2590 |
|
|
2016
Q2 | $25.2M | Sell |
3,228,635
-668,430
| -17% | -$5.73M | 0.06% | 425 |
|
|
2016
Q1 | $30.1M | Sell |
3,897,065
-983,262
| -20% | -$7.2M | 0.08% | 320 |
|
|
2015
Q4 | $52.7M | Buy |
4,880,327
+4,548,098
| +1,369% | +$41.3M | 0.11% | 221 |
|
|
2015
Q3 | $2.3M | Buy |
+332,229
| New | +$2.71M | ﹤0.01% | 1812 |
|
|
2015
Q2 | – | Sell |
-1,239,593
| Closed | -$12.2M | – | 4053 |
|
|
2015
Q1 | $12.2M | Sell |
1,239,593
-496,370
| -29% | -$6.2M | 0.02% | 917 |
|
|
2014
Q4 | $21.3M | Buy |
1,735,963
+350,798
| +25% | +$4.28M | 0.05% | 577 |
|
|
2014
Q3 | $13.8M | Buy |
1,385,165
+935,251
| +208% | +$8.68M | 0.04% | 690 |
|
|
2014
Q2 | $3.41M | Buy |
449,914
+439,014
| +4,028% | +$1.75M | 0.01% | 1437 |
|
|
2014
Q1 | $36K | Sell |
10,900
-21,200
| -66% | -$74.2K | ﹤0.01% | 3367 |
|
|
2013
Q4 | $107K | Buy |
32,100
+1,935
| +6% | +$5.62K | ﹤0.01% | 3337 |
|
|
2013
Q3 | $91K | Buy |
30,165
+10,165
| +51% | +$69.7K | ﹤0.01% | 3192 |
|
|
2013
Q2 | $164K | Buy |
+20,000
| New | +$153K | ﹤0.01% | 2803 |
|
Millennium Management's ACHN Position: Q1 2020 in Review
Millennium Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 548,616 shares — an estimated $3.31M sold.
Millennium Management first reported a position in ACHN in Q2 2013 and held it in 26 quarters. The position peaked at $52.7M in Q4 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Millennium Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Millennium Management sold 548,616 Achillion Pharmaceuticals shares in Q1 2020, an estimated $3.31M.
- Millennium Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 26 quarters.
- Millennium Management's Achillion Pharmaceuticals position peaked at $52.7M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.